| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |
| Psychiatric Bulletin | Advances in Psychiatric Treatment | All RCPsych Journals |
|
|
|
||||||||||
|
||||||||||||
The British Journal of Psychiatry 173: 242-248 (1998)
© 1998 The Royal College of Psychiatrists
FM Quitkin, PJ McGrath, JW Stewart, K Ocepek-Welikson, BP Taylor, E Nunes, D Delivannides, V Agosti, SJ Donovan, D Ross, E Petkova and DF Klein
Department of Therapeutics, Columbia University College of Physicians and Surgeons, New York State Psychiatric Institution, USA.
BACKGROUND: In spite of the virtually ubiquitous nature of the initial 10-day placebo run-in period (IPR) in drug trials, there is little empirical data establishing its relevance. METHOD: Data from 593 subjects were examined retrospectively to determine whether or not the prognosis of subjects minimally improved during the IPR was different to those who were unimproved. The IPR period was single-blind and was followed by a six-week double-blind phase in all studies. RESULTS: Twenty-six per cent of the subjects were minimally improved and 74% were unimproved. Approximately 10% of the subjects who were much improved were not followed systematically. Across a range of diagnosis, severity and chronicity subjects minimally improved (versus unimproved) after IPR had a more favourable prognosis whether assigned to drug or placebo. CONCLUSIONS: Change during IPR appears to be a meaningful predictor. Stratification should be considered in future antidepressant studies.
This article has been cited by other articles:
|
|
 |
|
  A. M. Hunter, A. F. Leuchter, M. L. Morgan, and I. A. Cook Changes in Brain Function (Quantitative EEG Cordance) During Placebo Lead-In and Treatment Outcomes in Clinical Trials for Major Depression Am J Psychiatry, August 1, 2006; 163(8): 1426 - 1432. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 A. K. Vallance Something out of nothing: the placebo effect Advan. Psychiatr. Treat., July 1, 2006; 12(4): 287 - 296. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 R. H. Dworkin, J. Katz, and M. J. Gitlin Placebo response in clinical trials of depression and its implications for research on chronic neuropathic pain Neurology, December 29, 2005; 65(12_suppl_4): S7 - S19. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 T. E. Oxman and A. Sengupta Treatment of Minor Depression Am J Geriatr Psychiatry, June 1, 2002; 10(3): 256 - 264. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 A. Lakoff The Mousetrap: Managing the Placebo Effect in Antidepressant Trials Mol. Interv., April 1, 2002; 2(2): 72 - 76. [Full Text] [PDF]
|
|
|
|
|
|
A. F. Leuchter, I. A. Cook, E. A. Witte, M. Morgan, and M. Abrams Changes in Brain Function of Depressed Subjects During Treatment With Placebo Am J Psychiatry, January 1, 2002; 159(1): 122 - 129. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
F. M. Quitkin Placebos, Drug Effects, and Study Design: A Clinician's Guide Am J Psychiatry, June 1, 1999; 156(6): 829 - 836. [Abstract] [Full Text]
|
|
| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |
| Psychiatric Bulletin | Advances in Psychiatric Treatment | All RCPsych Journals |
